Class IIOngoingD-0384-2024
Drug recall · March 20, 2024
hyalogic For Dry Eyes recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
hyalogic For Dry Eyes, HylaTears", Lubricant Eye Drops, 0.67 FL OZ (20mL) bottle, Manufactured for hyalogic, 610 NW Platte Valley Dr., Riverside, MO 64150
- Lots / codes
All lots within Expiry
- Quantity
- 46,621 bottles
- Company
- Optikem International, Inc., Denver, CO
- Distribution
- Product distributed Nationwide in the USA
- Initiated
- February 29, 2024 · Voluntary: Firm initiated
- Classified
- March 12, 2024
- Reported
- March 20, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingMar 20, 2024TRP Natural Eyes Allergy Eyes ReliefOptikem International, Inc. · D-0375-2024Class IIOngoingMar 20, 2024TRP Blur ReliefOptikem International, Inc. · D-0376-2024Class IIOngoingMar 20, 2024TRP Eye Twitching ReliefOptikem International, Inc. · D-0377-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Dryness ReliefOptikem International, Inc. · D-0378-2024Class IIOngoingMar 20, 2024TRP Eye strain ReliefOptikem International, Inc. · D-0379-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Floaters ReliefOptikem International, Inc. · D-0380-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Aging Eye ReliefOptikem International, Inc. · D-0381-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Pink Eye ReliefOptikem International, Inc. · D-0382-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Red Eye ReliefOptikem International, Inc. · D-0383-2024
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.